Sobrera Pharma AB

ABActive

Org 5592026271Karl Gustavsgatan 12 B, 411 25 GöteborgResearch and experimental development on natural sciences and engineering· NACE 7210Est. 2019 · 7 years old1-4 employees

Overview Financials People & ownership Related companies

Sobrera Pharma AB is a Swedish AB based in Göteborg, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2019, the company reported revenue of SEK 0 in its latest annual filing.

Revenue 2024

SEK 0

EBITDA margin

—

Net profit 2024

SEK -5M

-11% vs 2023

Key ratios

See full ratios →

84.3%

This company

20202024

5.6×

This company

20202024

-8.4%

This company

20202024

EBITDA — year on year

SEK millions

Key figures

Annual report 2024

Revenue	SEK 0	—
EBITDA	SEK -4,7M	+1%
Net profit	SEK -5M	-11%
Total assets	SEK 59,6M	+5%
Equity	SEK 50,2M	-9%
Employees	—	—

Contact

Address

Karl Gustavsgatan 12 B, 411 25 Göteborg

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of Sobrera Pharma AB?

Sobrera Pharma AB is registered with Bolagsverket / SCB under Org 5592026271.

Who is the CEO of Sobrera Pharma AB?

Lena Ann-Charlotte Rosendahl is the CEO of Sobrera Pharma AB, in role since 2020.

Who is the chairman of Sobrera Pharma AB?

Jan-Fredrik Wilhelm Backman chairs the board of Sobrera Pharma AB, in role since 2025.

Where is Sobrera Pharma AB headquartered?

Sobrera Pharma AB's registered address is Karl Gustavsgatan 12 B.

Sobrera Pharma AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Sobrera Pharma AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Sobrera Pharma AB